$TBPH Theravance Biopharma, Inc. Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in Theravance Biopharma, Inc..

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of insider trading in Theravance Biopharma, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Theravance Biopharma, Inc. for free.

CIK Number: 0001583107
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: TBPH
Company Address: UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN KY1-1104

Theravance Biopharma, Inc. operates as a biopharmaceutical company. It focuses on the discovery, research, development, and commercialization of small molecule medicines. Its products include telavancin under the VIBATIV brand, revefenacin under the TD 4208 brand, and neprilysin. The company was founded in July 2013 and is headquartered in George Town, Cayman Islands.

Market Capitalization: $1.64B
Prev close: $30.60
Average Daily Volume: 346,635
Days Low: $30.63
Year Low: $13.59
Year High: $38.92

Theravance Biopharma, Inc. Insiders Active In Last 3 Months

NamePositionTotal SharesCurrent Value ($)Last 3 MonthsBuy / SellLast Transaction
BRADY ANNPresident, TBIL73,2572,241,664shares bought: 0 / shares sold: -4,096 STRONG SELLMay 22 201928 days ago
BROSHY ERANDirector34,5711,057,873shares bought: 28,571 / shares sold: 0 STRONG BUYMay 02 20192 months ago
Gunderson Robert V JRDirector51,6301,579,878shares bought: 28,571 / shares sold: 0 STRONG BUYMay 02 20192 months ago
HAUMANN BRETT KSVP Clin Dev & Chief Med Ofc236,6787,242,347shares bought: 245,000 / shares sold: -138,830 STRONG BUYMay 22 201928 days ago
HEGDE SHARATHCHANDRA SSVP, Research262,1728,022,463shares bought: 260,000 / shares sold: -78,993 STRONG BUYMay 22 201928 days ago
MALKIEL BURTON GDirector65,1421,993,345shares bought: 59,571 / shares sold: 0 STRONG BUYMay 02 20192 months ago
MITCHELL DEAN JDirector34,5711,057,873shares bought: 28,571 / shares sold: 0 STRONG BUYMay 02 20192 months ago
Molineaux SusanDirector8,385256,581shares bought: 28,571 / shares sold: 0 STRONG BUYMay 02 20192 months ago
O'Connor DonalDirector30,244925,466shares bought: 28,571 / shares sold: -4,000 STRONG BUYMay 20 201930 days ago
PASQUALONE FRANKSVP, Chief Comm Ops Officer323,0949,886,676shares bought: 249,000 / shares sold: -67,380 STRONG BUYMay 22 201928 days ago
PITZER KENNETH RSVP, Prod Strat & Comm Plng264,3788,089,967shares bought: 269,000 / shares sold: -68,183 STRONG BUYMay 22 201928 days ago
RINGROSE PETER SDirector37,9991,162,769shares bought: 28,571 / shares sold: 0 STRONG BUYMay 02 20192 months ago
SABESAN VIJAYSVP, Technical Operations149,2254,566,285shares bought: 0 / shares sold: -6,042 STRONG SELLMay 22 201928 days ago
Shafer Bradford JEVP, Gen. Counsel, Secretary181,9855,568,741shares bought: 279,000 / shares sold: -238,477 BUYMay 22 201928 days ago
Smaldone Alsup LaurieDirector18,347561,418shares bought: 18,347 / shares sold: 0 STRONG BUYMay 02 20192 months ago
WHITESIDES GEORGE MDirector200,9636,149,468shares bought: 32,571 / shares sold: -21,012 BUYMay 02 20192 months ago
Winningham Rick EChief Executive Officer1,091,81133,409,417shares bought: 768,000 / shares sold: -190,975 STRONG BUYMay 22 201928 days ago
WORBOYS PHILIP DSVP, Translational Science269,3998,243,609shares bought: 269,000 / shares sold: -79,840 STRONG BUYMay 22 201928 days ago
YOUNG WILLIAM DDirector51,6951,581,867shares bought: 28,571 / shares sold: 0 STRONG BUYMay 02 20192 months ago

View all Theravance Biopharma, Inc. insiders.

Theravance Biopharma, Inc. Latest Insider Transactions

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
May 22 2019TBPHTheravance Biophar ...WORBOYS PHILIP DSVP, Translational ...Payment of ExerciseF19.842,27245,076269,399271.7 K to 269.4 K (-0.84 %)
May 22 2019TBPHTheravance Biophar ...Winningham Rick EChief Executive Off ...Payment of ExerciseF19.848,678172,1721,091,8111.1 M to 1.1 M (-0.79 %)
May 22 2019TBPHTheravance Biophar ...Shafer Bradford JEVP, Gen. Counsel, ...Payment of ExerciseF19.842,48849,362181,985184.5 K to 182 K (-1.35 %)
May 22 2019TBPHTheravance Biophar ...SABESAN VIJAYSVP, Technical Oper ...Payment of ExerciseF19.841,47429,244149,225150.7 K to 149.2 K (-0.98 %)
May 22 2019TBPHTheravance Biophar ...PITZER KENNETH RSVP, Prod Strat & C ...Payment of ExerciseF19.842,27245,076264,378266.7 K to 264.4 K (-0.85 %)
May 22 2019TBPHTheravance Biophar ...PASQUALONE FRANKSVP, Chief Comm Ops ...Payment of ExerciseF19.841,60431,823323,094324.7 K to 323.1 K (-0.49 %)
May 22 2019TBPHTheravance Biophar ...HEGDE SHARATHCHANDRA SSVP, ResearchPayment of ExerciseF19.842,27245,076262,172264.4 K to 262.2 K (-0.86 %)
May 22 2019TBPHTheravance Biophar ...HAUMANN BRETT KSVP Clin Dev & Chie ...Payment of ExerciseF19.842,70553,667236,678239.4 K to 236.7 K (-1.13 %)
May 22 2019TBPHTheravance Biophar ...BRADY ANNPresident, TBILPayment of ExerciseF19.841,07321,28873,25774.3 K to 73.3 K (-1.44 %)
May 20 2019TBPHTheravance Biophar ...O'Connor DonalDirectorSellS20.192,67353,96827,57130.2 K to 27.6 K (-8.84 %)
May 20 2019TBPHTheravance Biophar ...O'Connor DonalDirectorSellS21.001,32727,86730,24431.6 K to 30.2 K (-4.20 %)
May 02 2019TBPHTheravance Biophar ...Molineaux SusanDirectorOption ExerciseA23.856,000143,1006,000
May 02 2019TBPHTheravance Biophar ...Molineaux SusanDirectorGrantA0.008,38508,3850 to 8.4 K
May 02 2019TBPHTheravance Biophar ...YOUNG WILLIAM DDirectorOption ExerciseA23.856,000143,1006,000
May 02 2019TBPHTheravance Biophar ...YOUNG WILLIAM DDirectorGrantA0.008,385051,69543.3 K to 51.7 K (+19.36 %)

View all Theravance Biopharma, Inc. insider transactions.